Venus Remedies Ltd Share Price
(VENUSREM)
₹311.55
as on 04:01PM, 29 Apr 2025
Venus Remedies Performance
Day's Low
Day's High
₹310.85Day's Price Range₹320.752 Week's Low
52 Week's High
₹270.2552-Week Price Range₹427.9
| Returns % | |
| 1 Month Return | -0.96 % |
| 3 Month Return | + 7.37 % |
| 1 Year Return | -4.06 % |
| Market Stats | |
| Previous Close | ₹313.20 |
| Open | ₹313.25 |
| Volume | 20.02K |
| Upper Circuit | ₹375.80 |
| Lower Circuit | ₹250.60 |
| Market Cap | ₹418.65Cr |
Venus Remedies Fundamentals
P/E Ratio
12.01
PEG Ratio
2.76
Market Cap
₹418.65 Cr
P/B Ratio
0.86
EPS
21.31
Dividend Yield
0Sector
Pharmaceuticals
ROE
6.18
Key events for Venus Remedies Ltd
Venus Remedies Stock Soars on FDA QIDP Approval - 17 Apr, 2025
Venus Remedies received QIDP designation from the FDA for its investigational antibiotic VRP-034, leading to a significant 14% stock surge, reaching an 8-week high.Venus Remedies Ensures SEBI Compliance - 11 Apr, 2025
Venus Remedies Limited has submitted a compliance certificate confirming proper processing of securities for dematerialisation for the quarter ending March 31, 2025, ensuring regulatory adherence and transparency.
Insights on Venus Remedies Ltd
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTProfit Spike
Netprofit is up for the last 3 quarters, 1.22 Cr → 19.6 Cr (in ₹), with an average increase of 73.7% per quarter
- POSITIVE IMPACT
FII Holding Up
Foreign Institutions have increased holdings from 1.11% to 1.34% in Mar 2025 quarter
- POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 3 quarters, 110.2 Cr → 188.8 Cr (in ₹), with an average increase of 21.9% per quarter
NO EFFECTAgainst Peers
In the last 1 year, Divis Laboratories Ltd has given 51.1% return, outperforming this stock by 55.1%
- NO EFFECT
Against Peers
In the last 3 years, Torrent Pharmaceuticals Ltd has given 137.0% return, outperforming this stock by 127.8%
- NO EFFECT
Promoter Holding Unchanged
Promoters holdings remained unchanged at 41.76% of holdings in Mar 2025 quarter
NEGATIVE IMPACTPrice Dip
In the last 7 days, VENUSREM stock has moved down by -7.1%
- NEGATIVE IMPACT
Retail Holding Down
Retail Investor have decreased holdings from 57.13% to 56.90% in Mar 2025 quarter
Venus Remedies Financials
Venus Remedies Shareholding Pattern
| Investors | Holdings % | FY Quarter | 3M change |
|---|---|---|---|
| Promoter Holdings | 41.76% | 0.00 | |
| Foreign Institutions | 1.34% | 0.00 | |
| Mutual Funds | 0% | 0.00 | |
| Retail Investors | 56.9% | 0.00 | |
| Others | 0% | 0.00 |
Venus Remedies Key Indicators
Venus Remedies Valuation
Venus Remedies in the last 5 years
Lowest (-45.34x)
September 23, 2020
Today (12.01x)
April 28, 2025
Industry (53.89x)
April 28, 2025
Highest (21.70x)
December 28, 2023
Venus Remedies Earnings and Dividends
Venus Remedies Ltd Earnings Results
Venus Remedies Ltd’s net profit jumped 186.13% since last year same period to ₹19.60Cr in the Q3 2024-2025. On a quarterly growth basis, Venus Remedies Ltd has generated 458.4% jump in its net profits since last 3-months.
Read More about Earnings Results
Venus Remedies Technicals Summary
Bearish
Neutral
Bullish
Venus Remedies Ltd is currently in a Bearish trading position according to technical analysis indicators.
Venus Remedies Peer Comparison
Company | Analyst View | Market Cap | 5 Year CAGR | Debt to Asset Ratio | Net Profit | Yearly Revenue |
|---|---|---|---|---|---|---|
| NA | ₹418.65 Cr | 108.1% | 0.54 | ₹28 Cr | ₹601 Cr | |
| NA | ₹781.95 Cr | 410.63% | 0.65 | ₹23 Cr | ₹307 Cr | |
| BUY | ₹14,454.88 Cr | 31.39% | 0.57 | ₹72 Cr | ₹6,702 Cr | |
| NA | ₹316.52 Cr | 30.9% | 0.55 | ₹5 Cr | ₹44 Cr | |
| NA | ₹426.11 Cr | 8.16% | 0.66 | ₹17 Cr | ₹367 Cr |
About Venus Remedies
Revenue: ₹176.86Cr as on December 2024 (Q4 24)
Net Profit: ₹19.60Cr as on December 2024 (Q4 24)
Listing date: 20 Dec, 2006
Chairperson Name: Pawan Chaudhary
| Organisation | Venus Remedies |
| Headquarters | Panchkula |
| Industry | Pharmaceuticals |
| E-voting on shares | Click here to vote |
FAQs on Venus Remedies Ltd
What is Venus Remedies Ltd price today?
Venus Remedies Ltd share price today stands at ₹311.55, Open: ₹313.25, Previous Close: ₹313.2, High: ₹320.7, Low: ₹310.85, 52 Week High: ₹427.9, 52 Week Low: ₹270.25.
How to Buy Venus Remedies Ltd Share in India?
- Get a PAN card
- Open a Demat account
- Open a Trading account
- Link your Demat account to your Trading account
- Fund your Trading account
- Place an order to buy Venus Remedies Ltd shares
What are today's traded volumes of Venus Remedies Ltd?
Today's traded volume of Venus Remedies Ltd(VENUSREM) is 20.02K.
What is today's market capitalisation of Venus Remedies Ltd?
Today's market capitalisation of Venus Remedies Ltd(VENUSREM) is ₹418.65Cr.
What is the 52 Week High and Low Range of Venus Remedies Ltd?
How much percentage Venus Remedies Ltd is down from its 52 Week High?
Venus Remedies Ltd (VENUSREM) share price is ₹311.55. It is down -27.19% from its 52 Week High price of ₹427.9
How much percentage Venus Remedies Ltd is up from its 52 Week low?
Venus Remedies Ltd (VENUSREM) share price is ₹311.55. It is up 15.28% from its 52 Week Low price of ₹270.25